Literature DB >> 3341169

Electrophysiologic effects of desethylamiodarone, an active metabolite of amiodarone: comparison with amiodarone during chronic administration in rabbits.

R Kato1, N Venkatesh, K Kamiya, S Yabek, R Kannan, B N Singh.   

Abstract

During acute superfusion studies by means of the standard microelectrode technique, we previously showed that both amiodarone and its major metabolite, desethylamiodarone, had a modest effect on the lengthening of the action potential duration (APD) at high drug concentrations and produced a rate-dependent block of the sodium channel in cardiac muscle. In this study the comparative electrophysiologic effects of the two compounds in rabbits treated chronically with these compounds were determined with particular reference to repolarization and sinus node automaticity. The changes were correlated with those in serum and tissue drug levels and in thyroid hormone indices. After 1 week neither compound had a significant effect on atrial or sinus nodal potentials; after 3 weeks, amiodarone increased the atrial APD at 90% repolarization time by 10.5% (p less than 0.05) and the effective refractory period (ERP) by 6.7% (p less than 0.05). The corresponding figures for desethylamiodarone were 13% (NS) and 18% (NS). The sinus cycle length was increased 12% (NS) by amiodarone and 27.9% (p less than 0.05) after the metabolite. In animals treated for 6 weeks, amiodarone increased the ventricular APD at 90% repolarization by 58.8% (p less than 0.01) and desethylamiodarone by 42.0% the corresponding figures for the ERP were 63.4% (p less than 0.01 and 47.4% (p less than 0.01), respectively. At the stimulation frequency used, neither compound exerted a significant effect on Vmax. Both amiodarone and desethylamiodarone significantly decreased serum triiodothyronine and increased reverse triiodothyronine levels but had no effect on thyroxine.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3341169     DOI: 10.1016/0002-8703(88)90481-4

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  9 in total

1.  Na+-K+ pump inhibition caused by chronic amiodarone in guinea pig myocardium.

Authors:  T Maruyama; N Ueda; Y Kaji; S Kanaya; T Fujino; Y Niho
Journal:  Heart Vessels       Date:  1999       Impact factor: 2.037

2.  Comparison of the chronic and acute effects of amiodarone on the calcium and potassium currents in rabbit isolated cardiac myocytes.

Authors:  A Varró; L Virág; J G Papp
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

Review 3.  Amiodarone in long term prophylaxis.

Authors:  D Katritsis; A J Camm
Journal:  Drugs       Date:  1991       Impact factor: 9.546

4.  Electrophysiological effects of dronedarone (SR 33589), a noniodinated amiodarone derivative in the canine heart: comparison with amiodarone.

Authors:  A Varró; J Takács; M Németh; O Hála; L Virág; N Iost; B Baláti; M Agoston; A Vereckei; G Pastor; M Delbruyère; P Gautier; D Nisato; J G Papp
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

Review 5.  Current treatment recommendations in antiarrhythmic therapy.

Authors:  I C Van Gelder; J Brügemann; H J Crijns
Journal:  Drugs       Date:  1998-03       Impact factor: 9.546

Review 6.  Amiodarone. An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias.

Authors:  J Gill; R C Heel; A Fitton
Journal:  Drugs       Date:  1992-01       Impact factor: 9.546

7.  Effects of long-term oral administration of amiodarone on the electromechanical performance of rabbit ventricular muscle.

Authors:  I Kodama; R Suzuki; K Kamiya; H Iwata; J Toyama
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

8.  Functional and pharmacological analysis of cardiomyocytes differentiated from human peripheral blood mononuclear-derived pluripotent stem cells.

Authors:  Michael Riedel; Chuanchau J Jou; Shuping Lai; Robert L Lux; Alonso P Moreno; Kenneth W Spitzer; Elizabeth Christians; Martin Tristani-Firouzi; Ivor J Benjamin
Journal:  Stem Cell Reports       Date:  2014-05-29       Impact factor: 7.765

9.  Prediction of the dose range for adverse neurological effects of amiodarone in patients from an in vitro toxicity test by in vitro-in vivo extrapolation.

Authors:  Engi Abd El-Hady Algharably; Emma Di Consiglio; Emanuela Testai; Reinhold Kreutz; Ursula Gundert-Remy
Journal:  Arch Toxicol       Date:  2021-02-19       Impact factor: 5.153

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.